| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/22/2009 | CA2234565C Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 12/22/2009 | CA2214636C Use of leukemia inhibitory factor and endothelin antagonists |
| 12/22/2009 | CA2205022C Adjuvant for a vaccine composition |
| 12/22/2009 | CA2181862C Mild newcastle disease virus vaccine |
| 12/22/2009 | CA2180309C Coccidiosis poultry vaccine |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/22/2009 | CA2104871C Prad1 cyclin (cyclin d1) and its cdna |
| 12/19/2009 | CA2633246A1 Identification of therapeutic agents for hiv infection |
| 12/17/2009 | WO2009152518A1 Novel peptide adjuvant for influenza vaccination |
| 12/17/2009 | WO2009152454A1 Methods for treating or preventing brain infections |
| 12/17/2009 | WO2009152298A1 Methods, compositions and and diagnostic kits for the detection and treatment for staphylococcal nasal decolonization using achromopeptidase |
| 12/17/2009 | WO2009152287A1 Use of histamine h4 antagonist for the treatment of post-operative adhesions |
| 12/17/2009 | WO2009152186A1 Methods for enhancing cell therapy efficacy including treatment with cd26 peptidase inhibitors |
| 12/17/2009 | WO2009152181A1 Cell-based systems for producing influenza vaccines |
| 12/17/2009 | WO2009152179A1 Compositions, methods, and kits for eliciting an immune response |
| 12/17/2009 | WO2009152147A2 Compositions and methods for dengue virus (dv) treatment and vaccination |
| 12/17/2009 | WO2009151717A2 Bcr-complex-specific antibodies and methods of using same |
| 12/17/2009 | WO2009151697A2 Compositions and processes relating to human bocavirus |
| 12/17/2009 | WO2009151634A1 Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis |
| 12/17/2009 | WO2009151620A2 Pain treatment using erk2 inhibitors |
| 12/17/2009 | WO2009151505A1 Devices and methods for immunoglobulin production |
| 12/17/2009 | WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 12/17/2009 | WO2009150835A1 Iqgap3 epitope peptides and vaccines containing the same |
| 12/17/2009 | WO2009150635A1 Treatment of chronic prostatitis |
| 12/17/2009 | WO2009150623A1 Treatment of chronic prostatitis |
| 12/17/2009 | WO2009150539A2 Variable domains of camelid heavy-chain antibodies directed against androctonus autralis hector toxins |
| 12/17/2009 | WO2009150532A1 Combined influenza vaccines for seasonal and pandemic protection |
| 12/17/2009 | WO2009150433A1 Immunogenic composition |
| 12/17/2009 | WO2009150429A2 Vaccine |
| 12/17/2009 | WO2009150419A1 Fructose biphosphate aldolase (fba) in neisseria |
| 12/17/2009 | WO2009150275A1 Human anti-dectin-1 antibody, hybridoma producing said antibody and applications thereof |
| 12/17/2009 | WO2009150146A1 Rift valley fever virus-like particles and their use for immunization and as test system |
| 12/17/2009 | WO2009149599A1 Liposome medicament and preparation method and use thereof |
| 12/17/2009 | WO2009149562A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | WO2009149560A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | WO2009131752A3 Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration |
| 12/17/2009 | WO2009130296A3 Anti-alk1 antibodies and uses thereof |
| 12/17/2009 | WO2009128963A3 Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof |
| 12/17/2009 | WO2009120922A3 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 12/17/2009 | WO2009120657A3 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents |
| 12/17/2009 | WO2009118662A3 Methods and compositions for treating bone loss |
| 12/17/2009 | WO2009106532A3 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 12/17/2009 | WO2009100376A3 Modification of antigens while maintaining antibody binding epitopes |
| 12/17/2009 | WO2009087467A3 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 12/17/2009 | WO2009085209A3 Methods for using and identifying modulators of delta-like 4 |
| 12/17/2009 | WO2009074861A3 Improved vaccine |
| 12/17/2009 | WO2008070135A8 Methods of treating systemic lupus erythematosus |
| 12/17/2009 | WO2008030282A3 Recombinant vaccine against bluetongue virus |
| 12/17/2009 | US20090312522 Synthetic active peptide fragments |
| 12/17/2009 | US20090312403 Compositions and methods for wt1 specific immunotherapy |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/17/2009 | US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 12/17/2009 | US20090312190 Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311779 Anti-p-selectin antibodies |
| 12/17/2009 | US20090311746 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 12/17/2009 | US20090311722 Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines |
| 12/17/2009 | US20090311669 Signal for packaging of influenza virus vectors |
| 12/17/2009 | US20090311665 Methods, compositions, and kits for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311334 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311290 Urogenital or anorectal transmucosal vaccine delivery system |
| 12/17/2009 | US20090311289 Vaccine |
| 12/17/2009 | US20090311288 Imidazoquinoxaline compounds as immunomodulators |
| 12/17/2009 | US20090311287 Novel flavivirus antigens |
| 12/17/2009 | US20090311285 Vaccine |
| 12/17/2009 | US20090311284 Recombinant Viral Proteins And Particles |
| 12/17/2009 | US20090311283 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 12/17/2009 | US20090311282 Neutralizing gdf8 epitope-based growth enhancing vaccine |
| 12/17/2009 | US20090311281 Novel method for down-regulation of amyloid |
| 12/17/2009 | US20090311280 Novel tnf receptor regulatory domain |
| 12/17/2009 | US20090311279 Colorectal Cancer Antigen |
| 12/17/2009 | US20090311278 Novel teleost derived antimicrobial polypeptides |
| 12/17/2009 | US20090311277 Nucleic acid compositions for stimulating immune responses |
| 12/17/2009 | US20090311276 Nanolipoprotein particles and related compositions, methods and systems |
| 12/17/2009 | US20090311275 Carrier for targeting nerve cells |
| 12/17/2009 | US20090311274 Polynucleotide coding tumor protein for use as preventive, diagnostic and prognostic tool in treatment of cell proliferative disorders |
| 12/17/2009 | US20090311273 Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 12/17/2009 | US20090311272 Methods and compositions for modulating angiogenesis and pericyte composition |
| 12/17/2009 | US20090311271 Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1) |
| 12/17/2009 | US20090311270 Methods, compositions, and kits for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311269 Methods for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311268 Cd40-binding activating antibodies |
| 12/17/2009 | US20090311267 Inhibition of VWF - GPIb/V/IX interaction and platelet-collagen interaction for prevention and treatment of cerebral attacks |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | US20090311265 Human binding molecules capable or neutralizing influenze virus h5n1 and uses thereof |
| 12/17/2009 | US20090311264 Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant Oncoses |
| 12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
| 12/17/2009 | US20090311262 Method for Diagnosing Cancers Expressing the HER2 Receptor or its Truncated Variants |
| 12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311259 maytansinoid drug moieties covalently linked by a linker to an antibody which binds to an ErbB receptor, or which binds to one or more tumor-associated antigens or cell-surface receptors; cancer |
| 12/17/2009 | US20090311258 Medicament for lct poisoning |
| 12/17/2009 | US20090311257 Human antibodies specific for gastrin materials and methods |
| 12/17/2009 | US20090311256 12 Human Secreted Proteins |
| 12/17/2009 | US20090311255 Preventing autoimmune disease |
| 12/17/2009 | US20090311254 Cd40 antibody formulation and methods |
| 12/17/2009 | US20090311253 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 12/17/2009 | US20090311252 Anti-activin antibodies and uses for promoting bone growth |
| 12/17/2009 | US20090311251 Scfv antibodies which pass epithelial and/or endothelial layers |